Serial anthropometry predicts peripheral nerve dysfunction in a community cohort
- 16 November 2012
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 29 (2) , 145-151
Abstract
Background Obesity is a risk factor for glucose intolerance, but the independent role of obesity in the development of peripheral neuropathy is unclear. This study assessed the impact of body size trajectories on prevalent nerve dysfunction in community‐dwelling women with and without glucose intolerance. Methods Annual (1996–2008) anthropometric measures of weight, height, waist circumference and body mass index [BMI, weight (kg)/height (m2)] were assessed in the Study of Women's Health Across the Nation – Michigan site. Glucose intolerance was defined annually on the basis of current use of diabetes medications, self‐reported diabetes diagnosis and, when available, fasting glucose. Peripheral nerve dysfunction in 2008 was defined as abnormal monofilament testing or ≥4 symptoms or signs. Linear mixed models were used to determine trajectories of anthropometry by subsequently identified nerve dysfunction status. Results Mean BMI was 32.4 kg/m2 at baseline, and 27.8% of the women had nerve dysfunction in 2008. BMI, weight and waist circumference increased over time. Women who would have nerve dysfunction were significantly larger than women without dysfunction, independent of glucose intolerance. At mean baseline age of 46, BMI, weight and waist circumference differed significantly (p‐value < 0.01) by subsequent nerve dysfunction status, independent of glucose intolerance and hypertension. These body size differences were maintained but not exacerbated over time. Conclusions Peripheral nerve dysfunction is prevalent among community‐dwelling women. Twelve years before the nerve assessment, anthropometry differed between women who would and would not have nerve dysfunction, differences that were maintained over time. Obesity deserves attention as an important and potentially modifiable risk factor for peripheral nerve dysfunction. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 43 references indexed in Scilit:
- Idiopathic neuropathy: new paradigms, new promiseJournal of the Peripheral Nervous System, 2012
- Impaired glucose tolerance and metabolic syndrome in idiopathic neuropathyJournal of the Peripheral Nervous System, 2012
- Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and ComplicationsDiabetic Medicine, 2012
- Peripheral Vascular Disease and Peripheral Neuropathy in Individuals With Cardiometabolic Clustering and ObesityDiabetes Care, 2011
- Is There a Clear Threshold for Fasting Plasma Glucose That Differentiates Between Those With and Without Neuropathy and Chronic Kidney Disease?: The Singapore Prospective Study ProgramAmerican Journal of Epidemiology, 2009
- Idiopathic neuropathy patients are at high risk for metabolic syndromeJournal of the Neurological Sciences, 2008
- Neuropathy: mobility and quality of lifeDiabetes/Metabolism Research and Reviews, 2008
- The Obesity Epidemic in the United States Gender, Age, Socioeconomic, Racial/Ethnic, and Geographic Characteristics: A Systematic Review and Meta-Regression AnalysisEpidemiologic Reviews, 2007
- Markers of inflammation, Vitamin E and peripheral nervous system functionNeurobiology of Aging, 2006
- Peripheral Insensate Neuropathy—A Tall Problem for US Adults?American Journal of Epidemiology, 2006